As of November 2024, KPC Pharmaceuticals has a market cap of $1.29B. This makes KPC Pharmaceuticals the world's 6719th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.17B | -2.97% |
2023 | $2.23B | 47.73% |
2022 | $1.51B | 27.78% |
2021 | $1.18B | 27.75% |
2020 | $925.98M | -19.38% |
2019 | $1.15B | 73.62% |
2018 | $661.57M | -32.46% |
2017 | $979.51M | -32.27% |
2016 | $1.45B | -32.14% |
2015 | $2.13B | 60.44% |
2014 | $1.33B | 5.21% |
2013 | $1.26B | 21.16% |
2012 | $1.04B | - |